These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 29901119)

  • 1. CRISPR therapeutic tools for complex genetic disorders and cancer (Review).
    Baliou S; Adamaki M; Kyriakopoulos AM; Spandidos DA; Panayiotidis M; Christodoulou I; Zoumpourlis V
    Int J Oncol; 2018 Aug; 53(2):443-468. PubMed ID: 29901119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Applications of ZFN, TALEN and CRISPR/Cas9 techniques in disease modeling and gene therapy].
    Zhao G; Pu J; Tang B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):857-862. PubMed ID: 27984622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-Specific Genome Engineering in Human Pluripotent Stem Cells.
    Merkert S; Martin U
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered CRISPR Systems for Next Generation Gene Therapies.
    Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
    ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
    Chaterji S; Ahn EH; Kim DH
    Theranostics; 2017; 7(18):4445-4469. PubMed ID: 29158838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing in Stem Cells for Disease Therapeutics.
    Song M; Ramakrishna S
    Mol Biotechnol; 2018 Apr; 60(4):329-338. PubMed ID: 29516417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basics of genome editing technology and its application in livestock species.
    Petersen B
    Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR based therapeutics: a new paradigm in cancer precision medicine.
    Das S; Bano S; Kapse P; Kundu GC
    Mol Cancer; 2022 Mar; 21(1):85. PubMed ID: 35337340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on genodermatoses using novel genome-editing tools.
    Lehmann J; Seebode C; Emmert S
    J Dtsch Dermatol Ges; 2017 Aug; 15(8):783-789. PubMed ID: 28622433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic applications of CRISPR RNA-guided genome editing.
    Koo T; Kim JS
    Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 therapies in experimental mouse models of cancer.
    Estêvão D; Rios Costa N; da Costa RG; Medeiros R
    Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic applications of CRISPR/Cas9 system in gene therapy.
    Mollanoori H; Teimourian S
    Biotechnol Lett; 2018 Jun; 40(6):907-914. PubMed ID: 29704220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases.
    Khan FA; Pandupuspitasari NS; Chun-Jie H; Ao Z; Jamal M; Zohaib A; Khan FA; Hakim MR; ShuJun Z
    Oncotarget; 2016 Aug; 7(32):52541-52552. PubMed ID: 27250031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editing the Mouse Genome Using the CRISPR-Cas9 System.
    Williams A; Henao-Mejia J; Flavell RA
    Cold Spring Harb Protoc; 2016 Feb; 2016(2):pdb.top087536. PubMed ID: 26832693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
    Chakraborty C; Teoh SL; Das S
    Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.